Schering-Plough
SGP
#544
Rank
$46.19 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: $2.04 Billion USD

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of $2.04 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008$2.04 B
2006$1.48 B198.39%
2005$0.49 B-395.83%
2004-$0.17 Billion265.22%
2003-$46 Million-102.01%
2002$2.29 B3.62%
2001$2.21 B-5.39%
2000$2.33 B
1998$1.92 B22.34%
1997$1.57 B38.9%
1996$1.13 B